A Study to Assess Nomlabofusp in Adolescents and Children With Friedreich's Ataxia

NCT06681766 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
18
Enrollment
INDUSTRY
Sponsor class

Stopped Review of Cohort 1 data facilitated direct enrollment into open label study and eliminate pause in study drug administration between PK study and open label study.

Conditions

Interventions

Sponsor

Larimar Therapeutics, Inc.